Uzedy - NDC Database
7 records found
Page:
51759-305 May 01, 2023
Uzedy 50 mg/.14ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 50 mg/.14ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
51759-410 May 01, 2023
Uzedy 75 mg/.21ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 75 mg/.21ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
51759-520 May 01, 2023
Uzedy 100 mg/.28ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 100 mg/.28ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
51759-630 May 01, 2023
Uzedy 125 mg/.35ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 125 mg/.35ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
51759-740 May 01, 2023
Uzedy 150 mg/.42ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 150 mg/.42ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
51759-850 May 01, 2023
Uzedy 200 mg/.56ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 200 mg/.56ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
51759-960 May 01, 2023
Uzedy 250 mg/.7ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Uzedy 250 mg/.7ml Subcutaneous Injection, Suspension, Extended Release by Teva Pharmaceuticals USA, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.